Edwards Lifesciences (EW) grants stock and options to strategy chief
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Donald E. Bobo Jr., CVP of Strategy and Corporate Development, reported new equity awards and related tax-withholding transactions in company stock. He received 7,850 restricted stock units and 7,850 performance rights on May 7, 2026 under the company’s Long-Term Stock Incentive Compensation Program. He was also granted 44,000 employee stock options with a conversion price of $82.76 per share, vesting in approximately equal monthly installments over 36 months starting one month after grant. The restricted stock units are scheduled to vest in four equal annual installments beginning one year after grant, while the performance-based units are scheduled to vest on May 7, 2029 based on three-year performance goals.
To cover tax obligations, Bobo had 831 shares disposed at $83.20 per share on May 7, 2026 and 1,038 shares disposed at $82.76 per share on May 8, 2026, both classified as tax-withholding dispositions rather than open-market sales. Following these transactions, he directly holds 26,778.2532 shares of common stock, with additional indirect holdings of 121,756 shares via a trust and 38,969.5756 shares through a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
BOBO DONALD E JR
Role
CVP,Strategy/Corp Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 1,038 | $82.76 | $86K |
| Grant/Award | Employee Stock Option (Right to Acquire) | 44,000 | $0.00 | -- |
| Grant/Award | Performance Rights | 7,850 | $0.00 | -- |
| Grant/Award | Common Stock | 7,850 | $0.00 | -- |
| Tax Withholding | Common Stock | 831 | $83.20 | $69K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 26,778.253 shares (Direct, null);
Employee Stock Option (Right to Acquire) — 44,000 shares (Direct, null);
Performance Rights — 7,850 shares (Direct, null);
Common Stock — 38,969.576 shares (Indirect, 401(k))
Footnotes (1)
- These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.
Key Figures
Restricted stock units granted: 7,850 shares
Performance rights target award: 7,850 shares
Employee stock options granted: 44,000 options at $82.76
+4 more
7 metrics
Restricted stock units granted
7,850 shares
Granted May 7, 2026; vesting in four equal annual installments
Performance rights target award
7,850 shares
Target performance-based units vesting May 7, 2029
Employee stock options granted
44,000 options at $82.76
Granted May 7, 2026; vest over 36 months; conversion price $82.76/share
Tax-withholding share dispositions
1,869 shares
831 shares at $83.20 and 1,038 shares at $82.76 to cover taxes
Direct common stock holdings
26,778.2532 shares
Direct ownership after May 8, 2026 tax-withholding transaction
Trust indirect holdings
121,756 shares
Indirect ownership by trust as of May 7, 2026 holding entry
401(k) indirect holdings
38,969.5756 shares
Indirect ownership via 401(k) as of May 7, 2026 holding entry
Key Terms
restricted stock units, Performance Rights, Employee Stock Option (Right to Acquire), Long-Term Stock Incentive Compensation Program, +1 more
5 terms
restricted stock units financial
"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Rights financial
"Security title: Performance Rights with underlying security title Common Stock"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
Employee Stock Option (Right to Acquire) financial
"Security title: Employee Stock Option (Right to Acquire) with conversion or exercise price 82.7600"
Long-Term Stock Incentive Compensation Program financial
"granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
tax-withholding disposition financial
"transaction action: tax-withholding disposition; transaction code description: Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What did Donald E. Bobo Jr. report in his latest Edwards Lifesciences (EW) Form 4?
Donald E. Bobo Jr. reported new equity compensation grants and related tax-withholding share dispositions. He received restricted stock units, performance rights, and stock options, while shares were automatically withheld to satisfy tax obligations tied to these awards, rather than being sold in open-market transactions.
How many restricted stock units and performance rights did EW grant to Donald E. Bobo Jr.?
He received 7,850 restricted stock units and 7,850 performance rights on May 7, 2026. The restricted stock units vest in four equal annual installments starting one year after grant, while the performance rights are scheduled to vest on May 7, 2029 based on three-year performance goals.
What stock options did Edwards Lifesciences grant to Donald E. Bobo Jr., and at what price?
He was granted 44,000 employee stock options with a conversion price of $82.76 per share on May 7, 2026. These options vest in approximately equal monthly installments over 36 months, commencing one month after the grant date, and are scheduled to expire on May 6, 2033.
How do the performance-based restricted stock units for EW vest for Donald E. Bobo Jr.?
The performance-based restricted stock units reflect a target award of 7,850 shares scheduled to vest on May 7, 2029. The actual number of shares that vest will depend on achieving specified performance goals over a three-year period, ranging from 0% to 200% of the target.